Solaris BioSciences

LONDON: Spectra Systems Corporation has increased its equity interest in Solaris (the principal shareholder of which is Dr. Lawandy, CEO of Spectra) from 4.79 percent to 48.65 percent  for an aggregate consideration of c.USD700,000. This transaction is expected to be…